FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
Links shared publicly online about this topic.
- 786total visits
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
View full resource at drugs.com
Tags: Digestion, Stomach, Cancer, Breast Cancer Medication, Stomach Cancer, FDA, Herceptin
Most Recently Shared on October 21, 2010 at 3:04 am By:
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer - http://bit.ly/bPZHjj
Pacific Oncology Hematology Associates
pacificoncology.com — “Pacific Oncology Hematology Associates” View full resource at pacificoncology.com
Most Recently Shared on November 2, 2010 at 6:47 pm By:
Pacific Oncology Physician Group
Herceptin Approved for HER2-positive Metastatic Stomach #Cancer | http://bit.ly/bLDdCT #oncology
Adding Multimedia FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) has approved Herceptin® (trastuzumab) in combination with chemotherap” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 2:05 pm By:
MNT Gastrointestinal Health News
Adding Multimedia FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer http://mnt.to/3Lzq #gastrointestinal
Herceptin approved for HER2-positive metastatic stomach cancer - ONA
oncologynurseadvisor.com — “Genentech announced that Herceptin (trastuzumab) has been approved in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic cancer of the stomach or gastroesophageal junction, in patients who have not received prior medicines for their metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 21, 2010 at 3:17 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Herceptin approved for HER2-positive metastatic stomach cancer http://goo.gl/fb/7pcEm
Herceptin approved for HER2-positive metastatic stomach cancer - MPR
empr.com — “Genentech announced that Herceptin (trastuzumab) has been approved in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic cancer of the stomach or gastroesophageal junction, in patients who have not received prior medicines for their metastatic disease.” View full resource at empr.com
Most Recently Shared on October 21, 2010 at 3:10 pm By:
MPR News: Herceptin approved for HER2-positive metastatic stomach cancer: Genentech announced that Herceptin (tras... http://bit.ly/cHeChY
Genentech: Newsroom: Approval in HER2-Positive Metastatic Stomach Cancer
gene.com — “Genentech: Newsroom: Approval in HER2-Positive Metastatic Stomach Cancer” View full resource at gene.com
Most Recently Shared on October 20, 2010 at 9:56 pm By:
Learn more about the FDA approval and stomach cancer http://tinyurl.com/24gez6t
Herceptin Now Approved In The EU For Patients With HER2-positive Advanced Stomach Cancer
mnt.to — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Herceptin (trastuzumab) in combination with chemotherapy for use in patients with HER2-positive metastatic st” View full resource at mnt.to
Most Recently Shared on January 30, 2010 at 2:32 pm By:
Naoto T. Ueno Physician, Doctor, Internist, and Oncologist
RT @cancer_tweets Herceptin Now Approved In The EU For Patients With HER2-positive Advanced Stomach Cancer Roche http://bit.ly/96mQAv
Advertisement
